SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021276
Filing Date
2022-11-02
Accepted
2022-11-02 16:31:18
Documents
67
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q oncr-20220930.htm   iXBRL 10-Q 2426873
2 EX-10.2 oncr-ex10_2.htm EX-10.2 71757
3 EX-31.1 oncr-ex31_1.htm EX-31.1 19745
4 EX-31.2 oncr-ex31_2.htm EX-31.2 19052
5 EX-32.1 oncr-ex32_1.htm EX-32.1 11815
6 EX-32.2 oncr-ex32_2.htm EX-32.2 11310
  Complete submission text file 0000950170-22-021276.txt   8567200

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20220930_lab.xml EX-101.LAB 409276
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oncr-20220930_cal.xml EX-101.CAL 46538
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oncr-20220930_def.xml EX-101.DEF 145846
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20220930_pre.xml EX-101.PRE 292868
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20220930.xsd EX-101.SCH 46259
61 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20220930_htm.xml XML 1703182
Mailing Address 4 CORPORATE DRIVE ANDOVER MA 01810
Business Address 4 CORPORATE DRIVE ANDOVER MA 01810 857-320-6400
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39575 | Film No.: 221354618
SIC: 2834 Pharmaceutical Preparations